Exxonmobil Product Solutions CompanyDecember 11, 2025

FDA 483 - Exxonmobil Product Solutions Company - December 11, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exxonmobil Product Solutions Company

Record Details

Exxon mobil Product Solutions Company in Baton Rouge, LA, received a Form 483 following an inspection of its API manufacturing facility. The inspection revealed significant deficiencies in the firm's quality unit responsibilities, including inadequate change control, insufficient investigations into stability failures, and improper stability study practices. Additionally, the firm's cGMP training was found to be inadequate for pharmaceutical API manufacturing.

Company: Exxonmobil Product Solutions Company
Inspection Date: December 11, 2025
Product Type: Drugs
Office: New Orleans District Office
People: Rodney L. Tinzie
Brittny C. Cargo (Medical Officer at FDA)

Open in Dashboard

ID · 6260797e-3f8f-4f4d-b8fc-691b5763e5aa